InvestorsHub Logo
Followers 230
Posts 21496
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Thursday, 08/31/2023 5:05:55 PM

Thursday, August 31, 2023 5:05:55 PM

Post# of 90
$EVAX Get'r done Kanstrup! BEFORE this gets the notice. Get back over the $.


Mr. Kanstrup brings 25 years of life science experience and comes with a very strong track record in leading strategy development as well as business development and with a broad understanding of capital markets and investor relations in listed and unlisted companies. Mr. Kanstrup has held several senior leadership positions at Novo Nordisk, including Head of Biopharma Operations. Mr. Kanstrup will succeed Dr. Norlén as the Company’s new CEO on September 1, 2023.

Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVAX News